vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
13.60
-0.07 (-0.48%)
Nov 7, 2024, 4:00 PM EST - Market closed
vTv Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 45.53 | 9.45 | 12.13 | 13.42 | 5.75 | 1.78 | Upgrade
|
Short-Term Investments | 0.07 | 0.07 | 0.02 | 0.1 | 0.37 | 0.25 | Upgrade
|
Cash & Short-Term Investments | 45.59 | 9.51 | 12.14 | 13.52 | 6.12 | 2.03 | Upgrade
|
Cash Growth | 261.43% | -21.66% | -10.17% | 120.91% | 201.83% | -27.79% | Upgrade
|
Accounts Receivable | 0.31 | 0.1 | 0.17 | 0.06 | 0.16 | 0.01 | Upgrade
|
Other Receivables | - | - | - | 0.14 | - | - | Upgrade
|
Receivables | 0.31 | 0.1 | 12.42 | 0.19 | 0.16 | 0.01 | Upgrade
|
Prepaid Expenses | 0.3 | 1.04 | 2.54 | 1.91 | 0.94 | 0.81 | Upgrade
|
Total Current Assets | 46.2 | 10.66 | 27.09 | 15.62 | 7.22 | 2.84 | Upgrade
|
Property, Plant & Equipment | 0.26 | 0.36 | 0.56 | 0.68 | 0.85 | 1 | Upgrade
|
Long-Term Investments | - | - | 5.59 | 9.17 | 6.73 | 2.48 | Upgrade
|
Other Long-Term Assets | - | - | - | - | - | 2.94 | Upgrade
|
Total Assets | 46.46 | 11.02 | 33.24 | 25.47 | 14.79 | 9.27 | Upgrade
|
Accounts Payable | 6.79 | 4.08 | 2.46 | 1.88 | 1.93 | 2.23 | Upgrade
|
Accrued Expenses | - | 6.17 | 4.85 | 6.15 | 4.2 | 4.84 | Upgrade
|
Short-Term Debt | - | 0.19 | 0.22 | 0.26 | 0.08 | 0.14 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | - | 6.03 | Upgrade
|
Current Portion of Leases | 0.18 | 0.17 | 0.15 | 0.18 | 0.16 | 0.11 | Upgrade
|
Current Unearned Revenue | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.03 | Upgrade
|
Total Current Liabilities | 6.99 | 10.62 | 7.71 | 8.5 | 6.39 | 13.38 | Upgrade
|
Long-Term Leases | 0.08 | 0.17 | 0.34 | 0.49 | 0.68 | 0.83 | Upgrade
|
Long-Term Unearned Revenue | 18.67 | 18.67 | 18.67 | - | 1.01 | 1.03 | Upgrade
|
Other Long-Term Liabilities | 0.29 | 0.11 | 0.68 | 1.26 | 2.92 | 2.86 | Upgrade
|
Total Liabilities | 26.02 | 29.57 | 27.4 | 10.25 | 11 | 18.11 | Upgrade
|
Common Stock | 0.03 | 0.03 | 0.03 | 0.9 | 0.77 | 0.64 | Upgrade
|
Additional Paid-In Capital | 307.75 | 256.34 | 254.76 | 238.19 | 209.16 | 183.86 | Upgrade
|
Retained Earnings | -291.3 | -281.04 | -265.52 | -248.83 | -290.04 | -233.52 | Upgrade
|
Total Common Equity | 16.48 | -24.68 | -10.74 | -9.74 | -80.1 | -49.02 | Upgrade
|
Minority Interest | 3.96 | 6.13 | 16.58 | 24.96 | 83.9 | 40.18 | Upgrade
|
Shareholders' Equity | 20.44 | -18.55 | 5.84 | 15.22 | 3.79 | -8.84 | Upgrade
|
Total Liabilities & Equity | 46.46 | 11.02 | 33.24 | 25.47 | 14.79 | 9.27 | Upgrade
|
Total Debt | 0.26 | 0.53 | 0.72 | 0.93 | 0.92 | 7.11 | Upgrade
|
Net Cash (Debt) | 45.34 | 8.98 | 11.43 | 12.58 | 5.2 | -5.09 | Upgrade
|
Net Cash Growth | 271.69% | -21.38% | -9.20% | 141.84% | - | - | Upgrade
|
Net Cash Per Share | 18.63 | 4.31 | 5.95 | 8.03 | 4.42 | -6.72 | Upgrade
|
Filing Date Shares Outstanding | 2.43 | 2.43 | 2.04 | 1.67 | 1.44 | 1.05 | Upgrade
|
Total Common Shares Outstanding | 2.43 | 2.08 | 2.04 | 1.67 | 1.35 | 1.02 | Upgrade
|
Working Capital | 39.22 | 0.04 | 19.39 | 7.12 | 0.83 | -10.54 | Upgrade
|
Book Value Per Share | 6.77 | -11.84 | -5.27 | -5.82 | -59.28 | -47.92 | Upgrade
|
Tangible Book Value | 16.48 | -24.68 | -10.74 | -9.74 | -80.1 | -49.02 | Upgrade
|
Tangible Book Value Per Share | 6.77 | -11.84 | -5.27 | -5.82 | -59.28 | -47.92 | Upgrade
|
Machinery | - | 0.12 | 0.12 | 0.1 | 0.1 | 0.1 | Upgrade
|
Leasehold Improvements | - | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.